Prevalence of Hepatitis B Surface Antigen Among People Attending Medical Diagnostic Laboratories in Neyshabur, Northeast of Iran, During Years 2011 to 2015
To Cite:
Salehi
M, Najafi
S. Prevalence of Hepatitis B Surface Antigen Among People Attending Medical Diagnostic Laboratories in Neyshabur, Northeast of Iran, During Years 2011 to 2015,
Arch Pediatr Infect Dis.
2017
; 5(4):e61633.
doi: 10.5812/pedinfect.61633.
1.
Farzadegan H, Shamszad M, Noori-Arya K. Epidemiology of viral hepatitis among Iranian population--a viral marker study. Ann Acad Med Singapore. 1980; 9(2): 144-8[PubMed]
2.
Perz JF, Armstrong GL, Farrington LA, Hutin YJ, Bell BP. The contributions of hepatitis B virus and hepatitis C virus infections to cirrhosis and primary liver cancer worldwide. J Hepatol. 2006; 45(4): 529-38[DOI][PubMed]
3.
Andre F. Hepatitis B epidemiology in Asia, the Middle East and Africa. Vaccine. 2000; 18 Suppl 1-2[PubMed]
4.
Gust ID. Epidemiology of hepatitis B infection in the Western Pacific and South East Asia. Gut. 1996; 38 Suppl 2-23[PubMed]
5.
Alavian SM, Fallahian F, Lankarani KB. The changing epidemiology of viral hepatitis B in Iran. J Gastrointestin Liver Dis. 2007; 16(4): 403-6[PubMed]
6.
Joshi N, Yr NK, Kumar A. Age related seroprevalence of antibodies to hepatitis A virus in Hyderabad, India. Trop Gastroenterol. 2000; 21(2): 63-5[PubMed]
7. Iran's health and disease surveillance report (in Persian). 2001;
8.
Zali MR. Epidemiology of hepatitis B in the Islamic Republic of Iran. East Mediterr Health J. 1996; 2(2): 290-8
9.
Alavian SM, Hajarizadeh B, Ahmadzad-Asl M, Kabir A, Bagheri-Lankarani K. Hepatitis B Virus infection in Iran: A systematic review. Hepat Mon. 2008; 8(4): 281-94
10.
Salehi M,
Alavian SM,
Tabatabaei SV,
Izadi S,
Sanei Moghaddam E,
Amini Kafi-Abad S,
et al.
Seroepidemiology of HBV infection in South-East of iran; a population based study. Iran Red Crescent Med J. 2012; 14(5): 283-8[PubMed]
11.
Alavian SM,
Tabatabaei SV,
Nourizad S,
Mansouri F,
Khademi N,
Amini Kafi-abad S,
et al.
Seroepidemiology of hbv infection in kermanshah- west of iran; a population based study. Jundishapur J Microbiol. 2012; 5(4): 564-9[DOI]
12.
Alavian SM,
Tabatabaei SV,
Ghadimi T,
Beedrapour F,
Kafi-Abad SA,
Gharehbaghian A,
et al.
Seroprevalence of Hepatitis B Virus Infection and Its Risk Factors in the West of Iran: A Population-based Study. Int J Prev Med. 2012; 3(11): 770-5[PubMed]
13.
Farhat A, Khademi G, Mazlouman SJ. The prevalence of hepatitis B carrier state in Khorassan province of Iran. Saudi Med J. 2003; 24(5): 549-51[PubMed]
14.
Honigmann EBCE. Encyclopaedia of Islam. 2013;
15.
Lee BS,
Cho YK,
Jeong SH,
Lee JH,
Lee D,
Park NH,
et al.
Nationwide seroepidemiology of hepatitis B virus infection in South Korea in 2009 emphasizes the coexistence of HBsAg and anti-HBs. J Med Virol. 2013; 85(8): 1327-33[DOI][PubMed]
16.
Todd CS,
Abed AM,
Strathdee SA,
Scott PT,
Botros BA,
Safi N,
et al.
HIV, hepatitis C, and hepatitis B infections and associated risk behavior in injection drug users, Kabul, Afghanistan. Emerg Infect Dis. 2007; 13(9): 1327-31[DOI][PubMed]
17.
Amini S, Mahmoodi MF, Andalibi S, Solati AA. Seroepidemiology of hepatitis B, delta and human immunodeficiency virus infections in Hamadan province, Iran: a population based study. J Trop Med Hyg. 1993; 96(5): 277-87[PubMed]
18.
Alizadeh AH,
Ranjbar M,
Ansari S,
MirArab A,
Alavian SM,
Mohammad K,
et al.
Seroprevalence of hepatitis B in Nahavand, Islamic Republic of Iran. East Mediterr Health J. 2006; 12(5): 528-37[PubMed]
19.
Nazila K, Behrooz A, AbbasAli J, Ziba F, Peyman A. Hepatitis B Markers in Isfahan, central Iran: A population-based study. Hepat Mon. 2009; 9(1): 12-6
20.
Shakeri MT,
Foghanian B,
Nomani H,
Ghayour-Mobarhan M,
Nabavinia MS,
Rostami S,
et al.
The prevalence of hepatitis B virus infection in mashhad, iran: a population-based study. Iran Red Crescent Med J. 2013; 15(3): 245-8[DOI][PubMed]
21.
World Health Organization. . Introduction of hepatitis B vaccine into childhood immunization services: Management guidelines, including information for health workers and parents. 2001;
22.
Moosazadeh M, Amiresmaili MR, Nezammahalleh A. The epidemiology of HBsAg positive cases reported to the health deputy of Mazandaran University of Medical Sciences, Iran. J Health Dev. 2012; 1(2): 130-7
23.
Eskandar H, SayedJalal H, AbuulRahim M. Seroepidemiology of hepatitis B virus infection in Khuzestan province, southwest of Iran. Hepat Mon. 2009; 9(1): 34-8
24.
Mohebbi SR, Sanati A, Cheraghipour K, Rostami Nejad M, Shalmani HM, Zali MR. Hepatitis C and hepatitis B virus infection: epidemiology and risk factors in a large cohort of pregnant women in Lorestan, West of Iran. Hepat Mon. 2011; 11(9): 736-9[DOI][PubMed]
25.
Merat S,
Rezvan H,
Nouraie M,
Jamali A,
Assari S,
Abolghasemi H,
et al.
The prevalence of hepatitis B surface antigen and anti-hepatitis B core antibody in Iran: a population-based study. Arch Iran Med. 2009; 12(3): 225-31[PubMed]
26.
Ziaee M, Azarkar G. Prevalence of hepatitis d virus infection among patients with chronic hepatitis B attending birjand hepatitis clinic (East of iran) in 2012. Hepat Mon. 2013; 13(8)[DOI][PubMed]
27.
Saffar H,
Ajami A,
Saffar MJ,
Shojaei J,
Sotudeh-Anvari M,
Shams-Esfandabad K,
et al.
Prevalence of hepatitis B virus seromarkers in young adults vaccinated at birth; impact on the epidemiology of hepatitis B infection in iran. Hepat Mon. 2014; 14(5)[DOI][PubMed]
28.
Darmawan E, El-Khobar KE, Nursanty NK, Thedja MD, Muljono DH. Seroepidemiology and occult hepatitis B virus infection in young adults in Banjarmasin, Indonesia. J Med Virol. 2015; 87(2): 199-207[DOI][PubMed]
29.
Zhou Q,
Huang F,
Chen L,
Chen E,
Bai L,
Cheng X,
et al.
RPB5-Mediating Protein Suppresses Hepatitis B Virus (HBV) Transcription and Replication by Counteracting the Transcriptional Activation of Hepatitis B virus X Protein in HBV Replication Mouse Model. Jundishapur J Microbiol. 2015; 8(9)[DOI][PubMed]
30.
Ang LW, Cutter J, James L, Goh KT. Seroepidemiology of hepatitis B virus infection among adults in Singapore: a 12-year review. Vaccine. 2013; 32(1): 103-10[DOI][PubMed]
31.
Mahabadi M,
Norouzi M,
Alavian SM,
Samimirad K,
Azad TM,
Saberfar E,
et al.
Drug-related mutational patterns in hepatitis B virus (HBV) reverse transcriptase proteins from Iranian treatment-naive chronic HBV patients. Hepat Mon. 2013; 13(1)[DOI][PubMed]
Readers' Comments